Andreas Lindauer
Impact in
- Oncology top 5%
- Metal complexes synthesis and properties
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Modeling and Simulation top 5%
- Mathematical Biology Tumor Growth
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 3
- Cancer Treatment and Pharmacology 2
- Drug Transport and Resistance Mechanisms 2
- Metal complexes synthesis and properties 2
- Co-authors
- Ulrich Jaehde (8 shared papers)Jeroen Elassaiss‐Schaap (3 shared papers)Rik de Greef (3 shared papers)Friederike Kanefendt (3 shared papers)Uwe Fuhr (3 shared papers)Matthias Scheffler (1 shared paper)Oxana Doroshyenko (1 shared paper)Jürgen Wolf (1 shared paper)
- Journals
- CPT Pharmacometrics & Systems Pharmacology (5 papers)Clinical Pharmacokinetics (3 papers)Therapeutic Drug Monitoring (2 papers)Clinical Pharmacology & Therapeutics (1 paper)Journal of Pharmaceutical and Biomedical Analysis (1 paper)
- Partner nations
- GermanyUnited StatesBelgium
In The Last Decade
Andreas Lindauer
18 papers receiving 788 citations
Peers
Comparison fields: 5 of 83
- Oncology 469
- Modeling and Simulation 43
- Hematology 69
- Organic Chemistry 152
- Pharmacology 41
Countries citing papers authored by Andreas Lindauer
This map shows the geographic impact of Andreas Lindauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Lindauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Lindauer more than expected).
Fields of papers citing papers by Andreas Lindauer
This network shows the impact of papers produced by Andreas Lindauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Lindauer. The network helps show where Andreas Lindauer may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Lindauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 215 | |
| 2 | 2011 | 188 | |
| 3 | 2016 | 95 | |
| 4 | 2016 | 87 | |
| 5 | 2016 | 68 | |
| 6 | 2010 | 46 | |
| 7 | 2020 | 22 | |
| 8 | 2015 | 20 | |
| 9 | 2012 | 16 | |
| 10 | 2008 | 15 | |
| 11 | 2012 | 7 | |
| 12 | 2010 | 7 | |
| 13 | 2019 | 6 | |
| 14 | 2017 | 5 | |
| 15 | 2004 | 2 | |
| 16 | 2024 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 2005 | 1 | |
| 19 | 2025 | 0 |
About Andreas Lindauer
Andreas Lindauer is a scholar working on Oncology, Molecular Biology, Cardiology and Cardiovascular Medicine, Organic Chemistry and Pathology and Forensic Medicine, having authored 19 papers that have together received 804 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Mathematical Biology Tumor Growth (2 papers), Quinazolinone synthesis and applications (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Cancer Treatment and Pharmacology (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Metal complexes synthesis and properties (2 papers). The work is most often cited by research in Oncology (469 citations), Modeling and Simulation (43 citations), Hematology (69 citations), Organic Chemistry (152 citations) and Pharmacology (41 citations). Andreas Lindauer has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Ulrich Jaehde, Jeroen Elassaiss‐Schaap, Rik de Greef, Friederike Kanefendt, Uwe Fuhr, Matthias Scheffler, Oxana Doroshyenko, Jürgen Wolf, Bernhard K. Keppler and Frederike Lentz. Their work appears in journals such as CPT Pharmacometrics & Systems Pharmacology, Clinical Pharmacokinetics, Therapeutic Drug Monitoring, Clinical Pharmacology & Therapeutics and Journal of Pharmaceutical and Biomedical Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.